IRIS
MONTAGNA, DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.725
EU - Europa 1.930
AS - Asia 1.368
SA - Sud America 23
AF - Africa 7
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.061
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.702
CN - Cina 1.210
IE - Irlanda 598
UA - Ucraina 410
FI - Finlandia 274
DE - Germania 200
SE - Svezia 153
SG - Singapore 130
IT - Italia 129
GB - Regno Unito 75
FR - Francia 40
CA - Canada 23
BE - Belgio 21
BR - Brasile 21
CZ - Repubblica Ceca 7
IN - India 6
IR - Iran 5
LT - Lituania 5
MU - Mauritius 5
RU - Federazione Russa 5
AU - Australia 4
NL - Olanda 4
AT - Austria 3
BD - Bangladesh 3
EU - Europa 3
IS - Islanda 3
JP - Giappone 3
HK - Hong Kong 2
ID - Indonesia 2
VN - Vietnam 2
AR - Argentina 1
BA - Bosnia-Erzegovina 1
EC - Ecuador 1
EG - Egitto 1
GR - Grecia 1
HU - Ungheria 1
KR - Corea 1
MA - Marocco 1
MN - Mongolia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
TR - Turchia 1
Totale 6.061
Salva come PNG Salva come JPEG
Città #
Chandler 625
Dublin 597
Jacksonville 504
Nanjing 339
Boardman 196
Ashburn 155
Nanchang 145
Princeton 125
Hebei 115
Lawrence 104
Shenyang 104
Wilmington 102
Changsha 95
Ann Arbor 92
Beijing 86
Singapore 85
Medford 80
Tianjin 76
Jiaxing 75
Helsinki 70
Woodbridge 49
Hangzhou 42
Milan 37
Pavia 36
Shanghai 31
Brussels 21
Toronto 16
New York 15
Verona 15
Los Angeles 14
Norwalk 14
Des Moines 13
Fairfield 13
Seattle 10
Houston 9
Jinan 8
Lanzhou 8
Ningbo 8
Auburn Hills 7
Brno 7
Fuzhou 7
Taizhou 7
Chicago 6
Guangzhou 6
Kunming 6
Tappahannock 6
Zhengzhou 6
Falls Church 5
Washington 5
Andover 4
Ottawa 4
Borås 3
Changchun 3
Dallas 3
Fayetteville 3
Gallarate 3
Melbourne 3
Montichiari 3
Munich 3
Orange 3
Piscataway 3
Pune 3
Reykjavik 3
Zanjan 3
Belo Horizonte 2
Berlin 2
Cambridge 2
Cremona 2
Dhaka 2
Frankfurt am Main 2
Hanoi 2
Hong Kong 2
Leawood 2
Limeira 2
London 2
Marcignago 2
Mumbai 2
Palermo 2
Passirano 2
Phoenix 2
Redwood City 2
Sacramento 2
San Francisco 2
Shiojiri 2
Springfield 2
São Paulo 2
Wenzhou 2
Aracaju 1
Budapest 1
Cairo 1
Campina Grande 1
Campo Bom 1
Caçapava 1
Cedar Knolls 1
Civitavecchia 1
Cork 1
Cuiabá 1
Curitiba 1
Easton 1
Edmonton 1
Totale 4.303
Salva come PNG Salva come JPEG
Nome #
HLA-unrestricted killing of HSV-1-infected mononuclear cells. Involvement of either gamma/delta+ or alpha/beta+ human cytotoxic T lymphocytes. 106
Antigen-specific T cell response in infants after recombinant hepatitis B virus vaccination at birth: evaluation of T helper lymphocyte diversity 90
PaCS is a novel cytoplasmic structure containing functional proteasome and inducible by cytokines/trophic factors. 87
In vivo activated cord blood lymphocytes express high affinity interleukin-2 receptor: evaluation of their responsiveness to in vitro stimulation with recombinant interleukin-2. 81
Alloantigen-induced human lymphocytes rendered nonresponsive by a combination of anti-CD80 monoclonal antibodies and Cyclosporin-A suppress mixed lymphocyte reaction in vitro 77
Immunoterapia adottiva cellulare: illusione o realtà? 76
Analysis of immune reconstitution in children undergoing cord blood transplantation 74
The immunosuppressive effect of human cytomegalovirus infection in recipients of allogeneic hematopoietic stem cell transplantation 74
Alta frequenza di CTLp diretti contro blasti leucemici autologhi in pazienti pediatrici sottoposti a trapianto di midollo osseo allogenico: analisi clonale delle sottopopolazioni coinvolte nel fenomeno 73
Store-operated Ca2+ entry does not control proliferation in primary cultures of human metastatic renal cellular carcinoma 71
Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either g/d or a/b T cell receptor: role of accessory molecules on HLA-unrestricted killing virus infection targets 71
Low percentages of circulating CD8(+)/CD45RA(+) human T Lymphocytes expressing beta7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. 71
Haematopoietic and immune recovery after transplantation of cord blood progenitor cells in children 70
A novel self-lipid antigen targets human T cells against CD1c+ leukemias 69
Case report: long-lasting response in a patient with metastatic renal cell cancer receiving antitumor cytotoxic T lymphocytes 68
Autologous bone marrow transplantation for acute myeloid leukaemia in children using total body irradiation and melphalan as conditioning regimen 68
Characterisation of CTL directed towards non-inherited maternal alloantigens in human cord blood 67
Bone Marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation 67
Antigen-specific T cell response in infants after recombinant hepatitis B virus vaccination at birth: evaluation of T helper lymphocyte diversity 67
Alta frequenza di CTLp diretti contro blasti leucemici autologhi in pazienti pediatrici sottoposti a TMO allogenico. 66
An efficient strategy to induce and maintain in vitro human T cells specific for autologous non-small cell lung carcinoma. 66
Human CD86+ acute myeloid leukemia cells rapidly differentiate into dendritic cells unable of inducing cytotoxic T cell responses. 65
Recombinant human G-CSF-mobilized peripheral blood stem cells for second allogenic transplant after bone marrow graft rejection in children 65
Absence of IL-12Rβ2 in CD33(+)CD38(+) pediatric acute myeloid leukemia cells favours progression in NOD/SCID/IL2RγC-deficient mice. 65
Neonatal invariant Va24+ NKT lymphocytes are activated memory cells. 65
Modulating effect of growth hormone (GH) on PHA-induced lymphocyte proliferation 65
Human mesenchymal stem cells and Cyclosporin-A exert a synergistic suppressive effect on in vitro activation of alloantigen-specific cytotoxic lymphocytes 65
Allogeneic bone marrow transplantation in children from partially matched family donors. 64
Constitutive store-operated Ca2+ entry leads to enhanced nitric oxide production and proliferation in infantile hemangioma-derived endothelial colony-forming cells 63
T lymphocytes of recipient origin may contribute to the recovery of specific immune response toward viruses and fungi in children undergoing cord blood transplantation. 63
Depletion of alloreactive T cells by a specific anti-interleukin-2 receptor p55 chain immunotoxin does not impair in vitro antileukemia and antiviral activity. 61
Acquired immune deficiency syndrome in childhood: impaired production of interleukin-2 by HIV (LAV/HTLV III) infected patients. 61
Does the emergence and persistence of donor-derived leukemia-reactive cytotoxic T-lymphocytes protect patients given an allogeneic BMT from recurrence? Results of a preliminary study 59
Immune regulatory effect of human multipotent mesenchymal stromal cells: role of TLR3/TRL3-ligand interaction on in vitro umunoglobulin secretion 59
Acquired-immune-deficiency-syndrome In Childhood - Impaired Production of Interleukin-2 By Hiv (lav/htlv Iii) Infected Patients 59
Valutazione della frequenza di CTLp diretti verso gli antigeni non ereditati (NIMA) nel sangue placentare 58
High frequency of Epstein-Barr virus (EBV) lymphoblastoid cell line-reactive lymphocytes in cord blood: evaluation of cytolytic activity and IL-2 production 57
Evaluation of Immune-response of Waldeyer Tissues After Local Stimulation With Bacterial Ribosomal Extracts - Lymphocyte-b, Lymphocyte-t and Lymphocyte-nk Phenotype and Function 57
Lymphocyte subpopulations in the neonate: a subset of HNK-1-, OKT3-, OKT8+ lymphocytes displays natural killer activity. 57
NK cells play a predominant role in alloreactive cytolytic activity of cord blood lymphocytes (CBL). 57
Different polyubiquitinated bodies in human dendritic cells: IL-4 causes PaCS during differentiation while LPS or IFNα induces DALIS during maturation 57
Total body irradiation and melphalan is a safe and effective conditioning regimen of autologous bone marrow transplantation in children with acute myeloid leukemia in first remission. 56
Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia 56
Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling. 56
Seeing is believing: evidence of a novel cytoplasmic structure containing functional proteasome and inducible by cytokines/trophic factors. 55
Stim and Orai mediate constitutive Ca2+ entry and control endoplasmic reticulum Ca2+ refilling in primary cultures of colorectal carcinoma cells 55
Epstein-Barr virus and herpes simplex virus specific cytotoxic T-lymphocyte activity after bone matrrow transplantation in pediatric patients: pattern of recovery and correlation with virus-specific immune status of the donor 54
GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia. 54
An improved PCR-heteroduplex method permits high-sensitivity detection of clonal expansions in complex T cell populations. 54
Leukemia-specific CTLp in children whit leukemia given allogeneic or autologous BMT: a useful tool to predict the persistence of hematological remission? 54
Mobilization and selection of peripheral blood hematopoietic progenitors in children with systemic sclerosis 54
Does the emergence and persistence of donor-derived leukaemia-reactive cytotoxic T lymphocytes protect patients given an allogeneic BMT from recurrence? Results of a preliminary study. 53
La comparsa e la persistenza di CTLp leucemia-specifici dopo trapianto di midollo osseo è associata a un ridotto rischio di recidiva 53
Ex vivo generation and expansion of anti-tumor cytotoxic T-cell lines derived from patients or their HLA-identical sibling 53
Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. 53
Human alloantigen-specific anergic cells induced by a combination of CTLA4-Ig and CsA maintain anti-leukemia and anti-viral cytotoxic responses 52
Mechanisms of T-cell tolerance towards alloantigens 52
Interleukin-15 favors the expansion of central memory CD8+ T cells in ex vivo generated, antileukemia human cytotoxic T lymphocyte lines 51
Frequency of donor cytotoxic T cell precursors does not correlate with occurrence of acute graft-versus-host disease in children transplanted using unrelated donors 51
Direct inhibition of human acute myeloid leukemia cell growth by IL-12. 51
Hematopoietic and immune recovery after transplantation of cord blood progenitor cells in children. 51
N-glycosylation of HIV-gp120 may constrain recognition by T lymphocytes. 51
Identification of HLA-unrestricted CD8+/CD28- cytotoxic T-cell clones specific for leukemic blasts in children with acute leukemia. 51
Ex vivo priming for long-term maintenance of antileukemia human cytotoxic T cells suggests a general procedure for adoptive immunotherapy 50
Restricted TCR repertoire and long-term persistence of donor-derivered antigen-experienced CD4+ T cells in allogeneic bone marrow transplantation recipients 50
Recombinant human G-CSF-mobilized peripheral blood stem cells for second allogeneic transplant after bone marrow graft rejection in children. 50
High frequency of CTLp directed against autologous leukemic blasts and CMV infected fibroblasts after elimination of alloreactive T-cells 49
Ricostituzione immunologica dopo trapianto di cellule staminali placentari in pediatria 49
L’analisi della frequenza di CTLp leucemia-specifici in pazienti sottoposti a TMO autologo o allogenico può essere uno strumento per predire la permanenza in uno stato di remissione ematologica? 49
Natural cytotoxicity in the neonate: high levels of lymphokine activated killer (LAK) activity. 49
Nicotinic acid adenine dinucleotide phosphate (NAADP) induces intracellular Ca2+ release through the two-pore channel tpc1 in metastatic colorectal cancer cells 49
Expansion of antileukaemia CTL lines and clones for adoptive cell therapy in paediatric patients given allogeneic haematopoietic stem cell transplantation. 48
Feasibility and safety of adoptive immunotherapy with ex vivo-generated autologous, cytotoxic T lymphocytes in patients with solid tumor. 48
Induction of alloantigen-specific anergy does not impair cytolytic activity of leukemia-reactive human T cells. 48
In vitro killing of colorectal carcinoma cells by autologous activated NK cells is boosted by anti-epidermal growth factor receptor-induced ADCC regardless of RAS mutation status 48
Interleukin-27 Inhibits the Growth of Pediatric Acute Myeloid Leukemia in NOD/SCID/Il2rg-/- Mice. 47
Expression of CD45R0 antigen on the surface of resting and activated neonatal T lymphocyte subsets. 46
Discarded fraction from bone marrow erythrocyte depletion procedure is a good source of multipotent mesenchymal stromal cells 45
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. 44
Immunologia 43
Timely adaptation of a pediatric unit to COVID-19 emergency in Northern Italy: The experience of Fondazione IRCCS Policlinico San Matteo in Pavia 42
GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia. 41
Maccario. Does the emergence and persistence of donor-derived leukaemia-reactive cytotoxic T-lymphocytes protect patients given an allogeneic BMT from recurrence? Results of a preliminary study 41
Innovative approaches of adoptive immune cell therapy in pediatric recipients of ematomopietic stem cell transplantation 41
Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+T-cell subsets expressing a regulatory/suppressive phenotype 41
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19 41
Is adoptive T-cell therapy for solid tumors coming of age? 40
Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets. 40
Infusion of autologous Epstein-Barr (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication. 40
Safety and immunogenicity of a genetically engineered human immunodeficiency virus vaccine 39
Priming of CD4+ T cells specific for conserved regions of human immunodeficiency virus glycoprotein gp120 in humans immunized with a recombinant envelope protein. 38
Invariant NKT Cell Reconstitution in Pediatric Leukemia Patients Given HLA-Haploidentical Stem Cell Transplantation Defines Distinct CD4+ and CD4- Subset Dynamics and Correlates with Remission State 38
Hydrogen sulfide-evoked intracellular ca2+ signals in primary cultures of metastatic colorectal cancer cells 38
Immunotherapeutic Intervention against Sarcomas. 37
Frequency of donor cytotoxic T cell precursors does not correlate with occurrence of acute graft-versus-host disease in children transplanted using unrelated donors. 37
Emergence of antitumor cytolytic T cells is associated with maintenance of hematologic remission in children with acute myeloid leukemia. 37
Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia. 36
An immune-based biomarker signature is associated with mortality in COVID-19 patients. 36
null 34
Post-transplant emergence and persistence of leukemia-specific CTLp is associated with a lower risk of relapse. 33
Totale 5.533
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.928
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.928
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020276 0 0 0 0 0 0 12 83 9 114 55 3
2020/2021752 101 71 21 80 3 100 8 121 25 109 95 18
2021/2022536 6 2 14 14 8 33 8 50 26 23 87 265
2022/20231.716 171 110 22 150 187 202 0 112 706 7 36 13
2023/2024496 81 90 16 61 52 114 11 26 1 17 9 18
2024/2025393 22 145 44 55 46 81 0 0 0 0 0 0
Totale 6.147